3D-QSAR and Docking Studies on Pyrimidine Derivatives of Second-Generation ALK Inhibitors
Anaplastic lymphoma kinase (ALK) is a promising target for the treatment of non-small cell lung cancer. Under crizotinib treatment, drug resistance and progressive disease appeared after the point mutations arising in the kinase domain of ALK. Second-generation ALK inhibitors can solve the deficienc...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Georg Thieme Verlag KG,
2022-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |